How is the Evotec SE - ADR today?

The Evotec SE - ADR today is trading in the green, up by 5.03% at 3.97.

How has Evotec SE - ADR performed historically?

The Evotec SE - ADR is currently trading up 5.03% on an intraday basis in the past week the index fell -16.07%. The index has been down -5.92% in the past quarter and fell -15.17% in the past year. You can view this in the overview section.

What is Evotec SE - ADR Annual Revenue?

Evotec SE - ADR Annual Revenue rose 1.99%, in the last year to $796.97 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Evotec SE - ADR Annual Net Profit?

Evotec SE - ADR Annual Net Profit fell 133.67% in the last year to $196.08 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Evotec SE - ADR Price to Earning Ratio?

Evotec SE - ADR Price to Earning Ratio is -6, which is negative.

What is Evotec SE - ADR Stock Price?

Evotec SE - ADR Stock Price fell 15.17% and underperformed its sector by 70.64% in the past year.

What is Evotec SE - ADR Quarterly Revenue?

Evotec SE - ADR Quarterly Revenue fell 4.19% YoY to $199.98 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Evotec SE - ADR Quarterly Net profit?

Evotec SE - ADR Quarterly Net profit fell 52.75% YoY to $31.58 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Evotec SE - ADR Debt to Equity Ratio?

Evotec SE - ADR Debt to Equity Ratio of 0.47 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Evotec SE - ADR Return on Equity(ROE)?

Evotec SE - ADR Return on Equity(ROE) for the last financial year was -18.92%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Evotec SE - ADR Mutual Fund Holding?

Evotec SE - ADR Mutual Fund Holding increased by 0.01% in the last quarter to 3.62.

What is Evotec SE - ADR Interest Coverage Ratio?

Evotec SE - ADR Interest Coverage Ratio is -15.58, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Evotec SE - ADR Institutional Holding?

Evotec SE - ADR Institutional Holding increased by 0.07% in the last quarter to 6.73.

Evotec SE - ADR XNAS: EVO

Evotec SE - ADR Live Share Price Today, Share Analysis and Chart

Name: Evotec SE - ADR: Is Infosys Ltd. worth buying?
Item: Evotec SE - ADR
Rating: 1.720291625
Author: Trendlyne DVM scores

Momentum Trap

about

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including c...

3.97 0.19 (5.03%)

28.60% Fall from 52W High

392.9K XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Evotec SE - ADR is on 10 Jun 2025 for the purpose of Evotec SE Annual General Meeting for 2025 See details

Low Financial Strength

33.3 / 100

Expensive Valuation

25.7 / 100

Technically Neutral

45.3 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 63%

6 analysts

Evotec SE - ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Evotec SE - ADR Live Share Price Today, Share Analysis and Chart

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including c...

28.60% Fall from 52W High

Evotec SE - ADR Live Price Chart

Evotec SE - ADR FAQ

How is Evotec SE - ADR today?

Evotec SE - ADR today is trading in the green, and is up by 5.03% at 3.97.

How has Evotec SE - ADR performed historically?

Evotec SE - ADR is currently trading up 5.03% on an intraday basis. In the past week the stock fell -16.07%. stock has been down -5.92% in the past quarter and fell -15.17% in the past year. You can view this in the overview section.